Atrial hiPSC-CM as a pharmacological model to evaluate anti-AF drugs: Some lessons from IKur

2024-9-13

Peroxisome Proliferator-Activated Receptor Gamma Regulates Interleukin-6-Induced Lipoprotein (a) Gene Expression in Human HepG2 Cells

2024-9-13

PDE8 Inhibition and Its Impact on I Ca,L in Persistent Atrial Fibrillation: Evaluation of PDE8 as a Potential Drug Target

2024-9-13

Rethinking beta-blockers after ST-elevation myocardial infarction: essential for some, questionable for others

2024-9-6

Bivalirudin in Extracorporeal Membrane Oxygenation

2024-9-6

Editorial on: Canagliflozin mediates mitophagy through the AMPK/PINK1/PARKIN pathway to alleviate isoprenaline-induced cardiac remodelling

2024-8-30

Impact of adherence to beta-blockers in all-comers ST-segment elevation myocardial infarction (STEMI) patients and according to left ventricular ejection fraction (LVEF) at discharge: results from the real-world registry FAST-STEMI

2024-8-29

Kirenol alleviates inflammation and oxidative stress to improve myocardial ischemia/reperfusion injury in rats

2024-8-22

Erectile dysfunction risk among patients with diabetes mellitus using sodium–glucose cotransporter 2 inhibitors

2024-8-21

Canagliflozin mediates mitophagy through the AMPK/PINK1/PARKIN pathway to alleviate isoprenaline-induced cardiac remodelling

2024-8-13

Nrf2 ameliorates atrial fibrosis during antithrombotic therapy for atrial fibrillation by modulating CYP2C9 activity

2024-8-12

The Impact of Hydrogen Sulfide in the Paraventricular Nucleus on the MAPK Pathway in High Salt-Induced Hypertension

2024-8-8

SGLT2 Inhibitors, Malnutrition, Cachexia, and Survival in Heart Failure Patients with a History of Anthracycline Treatment

2024-8-7

Metolazone vs chlorothiazide in acute heart failure patients with diuretic resistance and renal dysfunction: a retrospective cohort study

2024-8-7

Commentary on Anti-thrombotic effect of protoparaxotriol saponins from Panax notoginseng using zebrafish model

2024-8-2

Acknowledgment of Reviewers

2024-8-1

CLINICAL PERFORMANCE AND PERSISTENCE ON DUAL PATHWAY INHIBITION WITH RIVAROXABAN AND ASPIRIN IN REAL-WORLD SETTING.

2024-8-1

Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients with Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis

2024-8-1

Is Metformin Cardioprotective? A New Piece to the Puzzle

2024-8-1

Antithrombotic treatment regimens in patients undergoing percutaneous coronary revascularization requiring oral anticoagulation: what real-world evidence shows us

2024-7-29

The efficacy of INa block to cardiovert atrial fibrillation is enhanced by inhibition of IK1.

2024-7-29

The combination of valsartan and spironolactone mitigated mitral regurgitation induced cardiac dysfunction in a novel rat model

2024-7-24

Valtrate suppresses TNFSF14-mediated arrhythmia after myocardial ischemia-reperfusion via inducing N-linked glycosylation of LTβR to regulate MGA/MAX/c-Myc/Cx43

2024-7-19

From Risk to Resilience: improved outcomes after myocardial infarction in patients with Sjogren’s syndrome

2024-7-19

Management of patients treated with oral anticoagulant therapy undergoing percutaneous coronary intervention with stent implantation: the PERSEO Registry

2024-7-19

Immunoglobulin-mediated Cardiac Protection from Ischemia/Reperfusion Injury in Diabetic Rats is associated with Endothelial Nitric Oxide Synthase/Glucose Transporter-4 Signaling Pathway

2024-7-16

Levosimendan as an Antidote in Experimental Calcium Channel Blocker Intoxication

2024-7-16

Cardiovascular outcomes of SGLT-2 Inhibitors Across BMI Spectrum in Heart Failure Patients: An Updated Systematic Review and Meta-Analysis

2024-7-8

Ivabradine approved and other uses in clinical practice: a systematic review

2024-7-8

Upregulation of Angiomotin-like 2 ameliorates experimental pulmonary arterial hypertension by inactivating YAP1 signaling

2024-7-2

Low-intensity heparin infusion compared to high-intensity heparin infusion dosing in patients with mechanical mitral valves: a retrospective cohort study

2024-7-2

A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea

2024-7-1

Dual Inhibition of Factor XIIa and Factor XIa Produces a Synergistic Anticoagulant Effect

2024-7-1

Comparative effectiveness and safety of intermittent, repeated or continuous use of levosimendan, milrinone, or dobutamine in patients with advanced heart failure: a network and single-arm meta-analysis

2024-7-1

Glutathione S-Transferase α4 Alleviates Hyperlipidemia- Induced Vascular Neointimal Hyperplasia in Arteriovenous Grafts via Inhibiting Endoplasmic Reticulum Stress

2024-7-1

EFFECTS OF PTEROSTILBENE ON HEART AND LUNG OXIDATIVE STRESS PARAMETERS IN TWO EXPERIMENTAL MODELS OF CARDIOVASCULAR DISEASE: MYOCARDIAL INFARCTION AND PULMONARY ARTERIAL HYPERTENSION

2024-7-1

Propranolol Alleviates Cardiac Injury After Acute Catecholamine Infusion via p38-MAPK Pathways

2024-7-1

Repetitive treatments with inotropes in advanced heart failure

2024-7-1

Are we Ready for Expanding the Use of Sodium-glucose Co-transporter-2 Inhibitors in Patients with Acute Myocardial Infarction?

2024-7-1

Use of 3D echocardiography facilitates analysis of thrombolytic efficacy in patients with persistent atrial fibrillation

2024-7-1

Treating Lows: Management of Orthostatic Hypotension

2024-6-25

Empagliflozin: primum inter pares among sodium-glucose cotransporter-2 inhibitors?

2024-6-25

Anthocyanins in vascular health and disease: mechanisms of action and therapeutic potential

2024-6-25

The potential impact of renin-angiotensin system inhibitors on cancer survival and recurrence: A systemic review and meta-analysis

2024-6-25

Sjogren syndrome and outcomes of acute myocardial infarction: A propensity-score matched analysis of the Nationwide Inpatient Sample 2005-2018

2024-6-19

Anti-thrombotic effect of protoparaxotriol saponins from Panax notoginseng using zebrafish model

2024-6-19

Quercetin protects against hypertensive renal injury by attenuating apoptosis: an integrated approach using network pharmacology and RNA-Seq

2024-6-4

Interleukin-1 Inhibition for the Prevention and Treatment of Heart Failure

2024-6-1

Interleukin-1 blockers for the treatment of recurrent pericarditis: pathophysiology, patient reported outcomes and perspectives

2024-6-1

Sulforaphane improves redox homeostasis and right ventricular contractility in a model of pulmonary hypertension

2024-6-1